1.30
-5.80%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About BrainAurora Medical Technology
Its shares trade on HKEX under the ticker 6681.HK. It has been listed since 8 January 2025. In the fiscal year to 31 December 2025, it reported revenue of CN¥256.6m and a net loss of CN¥367.2m. At that date it held total assets of CN¥855.0m and shareholders' equity of CN¥113.6m.
BrainAurora Medical Technology Ltd is a CN-based company operating in Health Care Technology industry. The company is headquartered in Shaoxing, Zhejiang. The company went IPO on 2025-01-08. BrainAurora Medical Technology Ltd is an investment holding company primarily engaged in offering cognitive impairment digital therapeutics (DTx) integral software solutions. The firm's main business is engaged in offering the system integral software solutions to hospitals which enables the hospitals to offer assessment and intervention to their cognitive impairment patients. The firm is also engaged in offering research projects services as well as technical and operational support services. The firm's main product is Brain Function Information Management Platform Software System, which enables clinical assessment and interventions for various types of cognitive impairment induced by vascular diseases, neurodegenerative diseases, psychological disorders and child development deficiencies, among other types of cognitive impairments. The firm mainly conducts its business in the domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 8 Jan 2025
- Employees
- 157
- Website
- 66nao.cn ↗
Leadership
Pay as last reported
- Mr. Zheng TanExecutive Chairman of the Board, Chief Strategy Officer, since 2023
- Mr. Junjie WangFinance Director, Joint Company Secretary
- Mr. Longjun CaiChief Operating Officer, Chief Technology Officer
- Mr. Zhiyuan LaiVice President - Market and Operations
- Mr. Xiaoyi WangExecutive Director, since 2023
- Mr. Ying Man ShamJoint Company Secretary
- Mr. Feng DengNon-Executive Director
- Ms. Mingqiu LiNon-Executive Director
- Mr. Sirui LiNon-Executive Director
- Mr. Yiu Por LamNon-Executive Independent Director
- Mr. Yuezhong LiNon-Executive Independent Director
- Mr. Duan TaoNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- BrainAurora Medical Technology Ltd employs 157 full-time employees in Shaoxing, CN.
- BrainAurora's main product is the Brain Function Information Management Platform Software System.
- BrainAurora offers cognitive impairment digital therapeutics (DTx) to hospitals in CN.
Weaknesses
- BrainAurora's business is primarily limited to the domestic market in CN.
- BrainAurora's main product focuses on cognitive impairment solutions in CN.
- BrainAurora has only 157 employees, which may limit scalability.
Opportunities
- BrainAurora can expand its cognitive impairment digital therapeutics (DTx) services to international markets.
- BrainAurora can leverage its Brain Function Information Management Platform Software System for global health care technology.
- BrainAurora can grow by offering research projects services to international clients.
Threats
- BrainAurora faces competition from other CN-based Health Care Technology companies.
- BrainAurora's reliance on the domestic CN market poses a risk for market saturation.
- BrainAurora's limited employee count of 157 may hinder rapid market expansion.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.